Conversion of Liver Allograft Recipients From Cyclosporine to FK 506-Based Immunosuppression: Benefits and Pitfalls

類似資料

• Conversion from Cyclosporine to FK 506 in Liver Allograft Recipients With Cyclosporine-Related Complications
  著者:: Fung, J.J., 等
  出版事項: (1990)
• CONVERSION OF LIVER ALLOGRAFT RECIPIENTS FROM CYCLOSPORINE TO FK506 IMMUNOSUPPRESSIVE THERAPY—A CLINICOPATHOLOGIC STUDY OF 96 PATIENTS
  著者:: Demetris, A. J., 等
  出版事項: (1992)
• FK 506 Used as Rescue Therapy for Human Liver Allograft Recipients
  著者:: Demetris, A.J., 等
  出版事項: (1991)
• CMV Infection in Liver Transplantation Under Cyclosporine or FK 506 Immunosuppression
  著者:: Alessiani, M., 等
  出版事項: (1991)
• FK 506 Versus Cyclosporine in Pediatric Liver Transplantation
  著者:: Tzakis, A.G., 等
  出版事項: (1991)